You are here

SIGA TECHNOLOGIES, INC.

Company Information
Address
SIGA TECHNOLOGIES, INC. 4575 SW RESEARCH WAY
CORVALLIS, OR -
United States



Information

UEI: VJRNRTSL22K4

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. ST-246 treatment of smallpox vaccine-related adverse events

    Amount: $2,998,540.00

    DESCRIPTION (provided by applicant): Naturally occurring smallpox has been eradicated but remains a credible threat to the security of the United States due to its potential use as an agent of terror ...

    SBIRPhase II2009Department of Health and Human Services National Institutes of Health
  2. Novel small molecule inhibitors of dengue replication

    Amount: $963,737.00

    DESCRIPTION (provided by applicant): There is an urgent need for new antivirals for both treatment and control of dengue virus, given that over 50 million people are infected worldwide with dengue eve ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  3. ST-246 treatment of smallpox vaccine-related adverse events in murine models

    Amount: $293,399.00

    DESCRIPTION (provided by applicant): The renewed threat of smallpox as a bioweapon and the emerging zoonotic threat of monkeypox highlight the need for effective poxvirus countermeasures. Use of the s ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  4. Enhancing the immune response to antigens delivered by the bacterial vector, Stre

    Amount: $273,956.00

    DESCRIPTION (provided by applicant): The focus of this proposal is to develop a safe, effective subunit vaccine delivery system. To accomplish this, we will utilize our bacterial commensal vector (BC ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  5. Antiviral Drugs for Lassa Fever Virus

    Amount: $5,790,460.00

    DESCRIPTION (provided by applicant): Hemorrhagic fever viruses are of serious worldwide health concern as well as potential biological weapons. Lassa fever virus in particular annually infects several ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  6. Small Molecule Inhibitors of Smallpox Virus Replication

    Amount: $4,789,380.00

    DESCRIPTION (provided by applicant): Concern over the use of variola virus as a biological weapon has prompted interest in development of small molecule therapeutics for smallpox. Variola virus is hig ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  7. Bacterial Commensal Vector Delivery/Smallpox Vaccine

    Amount: $491,430.00

    DESCRIPTION (provided by applicant): Smallpox is widely considered to be the most serious threat for use as a potential agent of biowarfare. There is an effective vaccine available (vaccinia virus), b ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  8. Lactococcal vaccine for strep throat

    Amount: $252,038.00

    DESCRIPTION (provided by applicant): There is currently no vaccine for "strep throat", which annually afflicts about 20 million persons in the US (mostly infants and children under 12 years of age). ...

    STTRPhase I2004Department of Health and Human Services National Institutes of Health
  9. Lactococcal vaccine for strep throat

    Amount: $252,038.00

    DESCRIPTION (provided by applicant): There is currently no vaccine for "strep throat", which annually afflicts about 20 million persons in the US (mostly infants and children under 12 years of age). ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  10. DEGP PROTEINASE INHIBITORS: NOVEL ANTI-INFECTIVES

    Amount: $0.00

    The DegP (HtrA) protease is essential for virulence in several Gram-negative pathogens: S. typhimurium, B. melitensis, Y. enterocolitica and P. aeruginosa. The phenotype of a degP knockout in Escheric ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government